Aster DM Healthcare Ltd's Q4FY25 Quarter Results
- 21 May 2025
Result Summary
- Aster DM Healthcare Ltd reported a 9.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
- Its expenses for the quarter were down by 5.4% QoQ and - - YoY.
- The net profit decreased 103.4% QoQ and - - YoY.
- The earnings per share (EPS) of Aster DM Healthcare Ltd declined at 0.5 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 977.67 | 1082.80 | 0.00 | -9.7% | - |
Total Expenses | 902.49 | 953.61 | 0.00 | -5.4% | - |
Profit Before Tax | 75.18 | 105.47 | - | -28.7% | NaN% |
Tax | 30.57 | 37.49 | 0.00 | -18.5% | - |
Profit After Tax | -2.17 | 64.39 | 0.00 | -103.4% | - |
Earnings Per Share | -0.50 | 1.10 | 0.00 | -145.5% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Aster DM Healthcare Ltd is a prominent healthcare services provider, primarily operating in the healthcare industry. The company offers a wide range of healthcare services, including hospitals, clinics, and diagnostic centers, catering to various healthcare needs. Aster DM Healthcare is known for its focus on delivering quality healthcare services across multiple countries, with significant operations in India and the Middle East. As of the latest data available, there are no specific major developments or changes within the company that are publicly disclosed. Therefore, the focus remains on their healthcare services and overall operations within the industry.
Revenue
In the fourth quarter of the fiscal year 2025, Aster DM Healthcare Ltd reported a total income of ₹977.67 crores. This represents a decrease of 9.7% compared to the previous quarter, Q3FY25, where the total income was ₹1082.80 crores. The year-over-year comparison is not available for Q4FY24 due to the absence of prior year data. The decline in total income from the previous quarter is a notable factor in this quarter's revenue performance.
Profitability
For Q4FY25, Aster DM Healthcare Ltd recorded a Profit Before Tax (PBT) of ₹75.18 crores, showing a reduction of 28.7% from Q3FY25's PBT of ₹105.47 crores. The tax expense for the quarter was ₹30.57 crores, which decreased by 18.5% compared to the previous quarter's tax of ₹37.49 crores. However, the company reported a negative Profit After Tax (PAT) of ₹-2.17 crores in Q4FY25, a significant decline from a positive PAT of ₹64.39 crores in Q3FY25, marking a change of -103.4% quarter-over-quarter. The Earnings Per Share (EPS) for Q4FY25 was ₹-0.50, a decline from ₹1.10 in Q3FY25, representing a 145.5% change quarter-over-quarter. The lack of available data from Q4FY24 restricts the year-over-year analysis.
Operating Metrics
The operating metrics for Aster DM Healthcare Ltd during Q4FY25 reflect a decrease in both total income and total expenses. Total expenses in the quarter amounted to ₹902.49 crores, a reduction of 5.4% from ₹953.61 crores in Q3FY25. The company's financial results for the quarter reveal a challenging period with decreased revenue and profitability metrics. The absence of year-over-year data for Q4FY24 limits the ability to assess long-term trends. Key financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio cannot be accurately calculated due to insufficient data provided. The focus remains on the quarter-over-quarter changes, which highlight the financial performance for Q4FY25.